dr. singh on research with antibody-drug conjugates in advanced bladder cancer
Published 4 years ago • 84 plays • Length 1:08Download video MP4
Download video MP3
Similar videos
-
0:58
dr. singh on combination therapy in localized bladder cancer
-
0:54
dr. singh on potential implications of the imvigor130 trial in bladder cancer
-
1:34
dr. singh on patient selection for immunotherapy in bladder cancer
-
0:16
copy of dr. singh on the role of chemotherapy in bladder cancer
-
1:31
dr. singh on novel therapies in advanced urothelial cancer
-
6:54
ai platform identifies patient-specific drug combinations for treatment of lymphoma
-
56:23
are you prepared for the new wave of adcs in nsclc? targeting her2, her3, trop2, and others
-
33:19
lecture: antibody drug conjugates — state of the art, trends, challenges, zaki sellam
-
1:06
dr. wong on antibody-drug conjugate research in multiple myeloma
-
0:52
dr. singh on investigational immunotherapy combinations in urothelial cancer
-
0:44
antibody-drug conjugates for advanced bladder cancer
-
31:39
the evolving role of antibody-drug conjugates in the treatment of urothelial carcinoma
-
2:30
the future of antibody-drug conjugates in urothelial cancer
-
27:03
antibody drug conjugates: the end of chemotherapy | 2023 west oncology conference
-
1:11
dr. singh on the role of chemotherapy in bladder cancer
-
7:09
understanding antibody drug conjugates
-
2:03
dr. marks on investigational antibody-drug conjugates in her2 breast cancer
-
1:29:20
experts discuss antibody-drug conjugates in breast, lung, & gi cancers - https://bit.ly/3rkkvzm
-
1:58
the role of antibody drug conjugates in lung cancer care
-
1:30
dr. english on an investigational antibody-drug conjugate in ovarian cancer
-
40:12
improving patient outcomes in urothelial carcinoma with novel antibody–drug conjugates
-
1:16
antibody-drug conjugates in advanced urothelial cancer: sacituzumab govitecan